Naglaa Ibrahim Mesbah1, Nehad Abd-El-Raheem Taha2, Zahra Nema Rahme1, Faten Fawzi Sukkar1, Dina Mohamed Omar3. 1. Department of Education and Training, Dasman Diabetes Institute, Kuwait City, Kuwait. 2. Department of Education and Training, Dasman Diabetes Institute, Kuwait City, Kuwait, nehad.taha@dasmaninstitute.org. 3. Department of Clinical Services, Dasman Diabetes Institute, Kuwait City, Kuwait.
Abstract
OBJECTIVES: We aimed to determine the quality of life (QoL) of Kuwaiti adults with type 1 diabetes mellitus (T1DM) who used continuous subcutaneous insulin infusions (CSIIs) and to understand their perception of this treatment. BACKGROUND: CSII is an effective and safe alternative to multiple daily injections for T1DM, with the potential to improve both glycemic control and QoL. Although CSII has been widely used in Kuwait, its effectiveness and benefits have not been properly evaluated. Healthcare providers and patients need more information on CSII before its initiation. METHODS: In this qualitative case study, semi-structured individual interviews were performed using a topic guide. Interviews were stopped at data saturation point. Subsequently, a thematic analysis of transcripts was performed. RESULTS: Eighteen adults with T1DM (8 males and 10 females; age 31.4 ± 6.4 years; diabetes duration 17.7 ± 9.5 years; CSII duration 3.6 ± 2.4 years) were recruited from the CSII clinic. Six main themes were studied: health benefits, lifestyle flexibility, improvement of mood and emotion, practical problems, physical and personal effects, and self-confidence to manage diabetes. CSII positively affected the QoL of participants', most notably by enhancing lifestyle flexibility; however, important negative qualities were also reported. CONCLUSION: The identified themes highlight the complexity of the experiences of participants, and can be used to provide a framework to help healthcare providers understand how people with T1DM become aware of their treatment regimens. It is important to identify the positive aspects of CSII and not focus only on its negative effects.
OBJECTIVES: We aimed to determine the quality of life (QoL) of Kuwaiti adults with type 1 diabetes mellitus (T1DM) who used continuous subcutaneous insulin infusions (CSIIs) and to understand their perception of this treatment. BACKGROUND: CSII is an effective and safe alternative to multiple daily injections for T1DM, with the potential to improve both glycemic control and QoL. Although CSII has been widely used in Kuwait, its effectiveness and benefits have not been properly evaluated. Healthcare providers and patients need more information on CSII before its initiation. METHODS: In this qualitative case study, semi-structured individual interviews were performed using a topic guide. Interviews were stopped at data saturation point. Subsequently, a thematic analysis of transcripts was performed. RESULTS: Eighteen adults with T1DM (8 males and 10 females; age 31.4 ± 6.4 years; diabetes duration 17.7 ± 9.5 years; CSII duration 3.6 ± 2.4 years) were recruited from the CSII clinic. Six main themes were studied: health benefits, lifestyle flexibility, improvement of mood and emotion, practical problems, physical and personal effects, and self-confidence to manage diabetes. CSII positively affected the QoL of participants', most notably by enhancing lifestyle flexibility; however, important negative qualities were also reported. CONCLUSION: The identified themes highlight the complexity of the experiences of participants, and can be used to provide a framework to help healthcare providers understand how people with T1DM become aware of their treatment regimens. It is important to identify the positive aspects of CSII and not focus only on its negative effects.
Authors: Thomas Danne; Wolfgang von Schütz; Karin Lange; Claudia Nestoris; Nicolin Datz; Olga Kordonouri Journal: Pediatr Diabetes Date: 2006-08 Impact factor: 4.866
Authors: S K McMahon; F L Airey; D A Marangou; K J McElwee; C L Carne; A J Clarey; E A Davis; T W Jones Journal: Diabet Med Date: 2005-01 Impact factor: 4.359
Authors: Jane E Yardley; Katherine E Iscoe; Ronald J Sigal; Glen P Kenny; Bruce A Perkins; Michael C Riddell Journal: Diabetes Technol Ther Date: 2012-12-06 Impact factor: 6.118
Authors: Richard M Bergenstal; David C Klonoff; Satish K Garg; Bruce W Bode; Melissa Meredith; Robert H Slover; Andrew J Ahmann; John B Welsh; Scott W Lee; Francine R Kaufman Journal: N Engl J Med Date: 2013-06-22 Impact factor: 91.245
Authors: Mauro Boronat; Rosa M Sánchez-Hernández; Julia Rodríguez-Cordero; Angelines Jiménez-Ortega; Francisco J Nóvoa Journal: Endocrinol Diabetes Metab Case Rep Date: 2015-01-01
Authors: T Battelino; I Conget; B Olsen; I Schütz-Fuhrmann; E Hommel; R Hoogma; U Schierloh; N Sulli; J Bolinder Journal: Diabetologia Date: 2012-09-11 Impact factor: 10.122
Authors: Lilian Tzivian; Jelizaveta Sokolovska; Anna E Grike; Agate Kalcenaua; Abraham Seidmann; Arriel Benis; Martins Mednis; Ieva Danovska; Ugis Berzins; Arnolds Bogdanovs; Emil Syundyukov Journal: Health Qual Life Outcomes Date: 2022-08-01 Impact factor: 3.077